1407PDerived neutrophil-to lymphocyte ratio (dNLR) change between baseline and cycle 2 is correlated with benefit during immune checkpoint inhibitors (ICI) in advanced non-small cell lung cancer (NSCLC) patients. (23rd October 2018) - Mezquita, L; Arbour, K; Auclin, E; Saravia, D; Rizvi, H; Hendriks, L; Planchard, D; Park, W; Nadal, E; Ruffinelli Rodriguez, J C; Ponce, S; Audigier-Valette, C; et al.